Pharma companies increasingly add nutraceutical products and product lines to their portfolios as these booming sectors offer faster and cheaper product development options with lower regulatory standards than drugs. We discussed these developments at the recent CPHI trade show in Milan, Italy, with Sirio Pharma, ADM and Beneo. Sara Lesina, general manager of Sirio Europe and Americas, tells Nutrition Insight that pharmaceutical companies are equipped to meet the regulatory standards in nutraceuticals as they are used to a higher quality level for pharma-grade products.
